MERCATELLI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 2.498
AS - Asia 1.188
EU - Europa 601
SA - Sud America 158
Continente sconosciuto - Info sul continente non disponibili 68
AF - Africa 30
OC - Oceania 2
Totale 4.545
Nazione #
US - Stati Uniti d'America 2.429
SG - Singapore 440
CN - Cina 273
VN - Vietnam 157
IT - Italia 151
BR - Brasile 108
GB - Regno Unito 87
DE - Germania 84
HK - Hong Kong 72
TR - Turchia 49
FR - Francia 43
BD - Bangladesh 41
CA - Canada 39
JP - Giappone 38
FI - Finlandia 34
ID - Indonesia 34
UA - Ucraina 34
AT - Austria 30
RU - Federazione Russa 29
PL - Polonia 28
SE - Svezia 26
AR - Argentina 25
IN - India 25
MX - Messico 16
IQ - Iraq 14
BE - Belgio 11
ES - Italia 11
ZA - Sudafrica 10
LT - Lituania 9
NL - Olanda 9
PK - Pakistan 9
VE - Venezuela 9
PH - Filippine 7
KE - Kenya 6
CH - Svizzera 4
JO - Giordania 4
UZ - Uzbekistan 4
CO - Colombia 3
EC - Ecuador 3
PR - Porto Rico 3
PS - Palestinian Territory 3
AU - Australia 2
BO - Bolivia 2
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
IR - Iran 2
MA - Marocco 2
MY - Malesia 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UG - Uganda 1
Totale 4.477
Città #
Ashburn 425
Singapore 320
San Jose 256
Fairfield 167
Woodbridge 157
Chandler 133
Beijing 120
Council Bluffs 114
Houston 114
Santa Clara 99
Ann Arbor 81
Hong Kong 72
Seattle 72
Wilmington 67
Cambridge 58
Ho Chi Minh City 50
Los Angeles 48
Jacksonville 37
Munich 36
New York 35
Hanoi 34
Tokyo 34
Ferrara 33
Jakarta 26
Milan 25
Vienna 24
Princeton 22
Warsaw 22
Izmir 20
Lauterbourg 20
Shanghai 18
Frankfurt am Main 16
London 16
Boardman 15
Buffalo 14
Dallas 14
Lappeenranta 13
São Paulo 13
Toronto 13
Montreal 12
Orem 12
Brussels 11
Atlanta 10
Brooklyn 10
Da Nang 10
Mexico City 10
Moscow 10
Nanjing 10
Poplar 10
Chennai 9
Denver 9
Johannesburg 9
The Dalles 9
Boston 8
Chicago 8
Helsinki 8
Baghdad 7
Biên Hòa 7
Manchester 7
Morciano Di Romagna 7
San Diego 7
San Francisco 7
Nanchang 6
Norwalk 6
Nuremberg 6
Phoenix 6
Shenyang 6
Stockholm 6
Belo Horizonte 5
Bremen 5
Buenos Aires 5
Charlotte 5
City of London 5
Haiphong 5
Istanbul 5
Kyiv 5
Nairobi 5
New Delhi 5
Redondo Beach 5
Turku 5
Ankara 4
Auburn Hills 4
Dhaka 4
Ottawa 4
Padua 4
Salt Lake City 4
Tianjin 4
Zurich 4
Amman 3
Amsterdam 3
Bari 3
Bến Tre 3
Can Tho 3
Cao Lanh 3
Caracas 3
Changsha 3
Des Moines 3
Dong Ket 3
Ferrara di Monte Baldo 3
Jackson 3
Totale 3.224
Nome #
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity 335
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists 313
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 277
Morphine and fentanyl differently affect MOP and NOP gene expression in human neuroblastoma SH-SY5Y cells 275
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes 221
N/OFQ system in brain areas of nerve-injured mice: its role in different aspects of neuropathic pain 218
Knock-in mice with NOP-eGFP receptors identify receptor cellular and regional localization 208
NOP receptor ligands and Parkinson’s disease 208
AT-1001: A high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology 206
Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4 191
Parkinson's disease: no NOP, new hope 188
Managing Parkinson's disease: moving ON with NOP 174
Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models 170
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity 166
Gene Co-expression Analysis Identifies Histone Deacetylase 5 and 9 Expression in Midbrain Dopamine Neurons and as Regulators of Neurite Growth via Bone Morphogenetic Protein Signaling 162
Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice 161
Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives 156
Early dysfunction of substantia nigra dopamine neurons in the parkinq311x mouse 141
Development of a new toolbox for mouse PET-CT brain image analysis fully based on CT images and validation in a PD mouse model 140
Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity 140
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for L-Dopa-induced dyskinesia 140
Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo 134
Enhancement of D1 dopaminergic responses in aged LRRK2 G2019S knock-in mice 116
Viral mediated α-synuclein overexpression results in greater transgene levels and α-synuclein overload in mice bearing kinase dead mutation of LRRK2 105
Totale 4.545
Categoria #
all - tutte 22.893
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.043
Totale 23.936


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022154 0 0 6 2 6 21 18 12 5 19 25 40
2022/2023299 23 49 11 44 42 30 25 19 29 0 17 10
2023/2024149 18 13 6 9 11 17 7 13 3 11 1 40
2024/2025577 11 17 55 8 73 99 9 15 68 69 94 59
2025/20262.178 252 40 142 264 351 134 283 119 204 258 94 37
2026/2027147 37 74 36 0 0 0 0 0 0 0 0 0
Totale 4.545